Clinical features of Guillain-Barré syndrome with anti-neurofascin 155 antibody.

Ning ZhaoSheng-Hui ChangQiu-Xia ZhangLin-Jie ZhangShu-Min JiangHui ZhaiLi Yang

Published in: Acta neurologica Scandinavica (2022)

Anti-NF155 antibody exists in a small portion of GBS patients. Anti-NF155 antibody-positive GBS patients possibly have a more severe clinical course, less sensory nerves involved, higher proportion of axonal type, poorer therapeutic effect, and worse prognosis, but the pathogenicity of the anti-NF155 antibody in GBS needs further study.

Keyphrases

signaling pathway
newly diagnosed
ejection fraction
lps induced
oxidative stress
spinal cord injury
nuclear factor
escherichia coli
cell proliferation
cystic fibrosis
early onset
staphylococcus aureus
patient reported
candida albicans